Press Releases

Sernova Corp, a clinical-stage regenerative medicine company announced that its human Phase I/II clinical trial for type-1 diabetes is advancing with additional patients for device and cell transplantation. Sernova announced on July 3, 2019, a case study describing preliminary data...

CURE Pharmaceutical , an innovative drug delivery and development company announced the allowance of U.S, which covers edible thin films with natural active ingredients located in both a powder coating and the film matrix for a bi-phasic release profile. “With...

Cryoport and EVERSANA have announced a strategic alliance to further create a fully integrated regenerative medicine supply chain solution. The alliance will be designed to leverage EVERSANA's position as the leading provider of commercial services addressing access, affordability and adherence...

"It is exciting news for MS patients in China that Gilenya has received fast approval. The approval of Gilenya and the upcoming regulatory review for Mayzent demonstrate our commitment to Chinese patients. We are proud that Gilenya already demonstrated...

Catalent Biologics announced a long-term strategic agreement for the development and manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), an AveXis gene therapy treatment for spinal muscular atrophy (SMA). Through this collaboration, AveXis, a Novartis company, will have dedicated manufacturing space at the...

Organized by China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), Informa Markets, and Shanghai Sinoexpo Informa Markets – saw record numbers of attendees as the pharma market in China continues to grow. The...

Swissport is investing in a state-of-the-art air cargo facility at Brussels Airport. While Brussels Airport Company is constructing the building, Swissport has signed a long-term lease and is investing several million euros in equipment and fittings for the new...